Poly MVA Survivors Website
. |
|
Cancer Testimonials |
|
Our
Poly MVA Support Group consists of survivors of
cancer who have bravely fought against various forms of Cancer and other
Degenerative diseases. Many of our members are
Stage 4 Cancer Survivors that
were diagnosed with various typles of metastatic cancer, like breast, colon,
lung and
prostate, who had been given little hope of
survival by existing conventional treatments.
Other members have a high incidence of Cancer in their families and are using Poly MVA(Lipoic
Acid Mineral Complex or LAMC) as an Alternative Cancer
Treatment in order to mitigate disease & aging.
Testimonials
| |
|
Throughout this website, each visitor will find dozens
of Poly MVA Testimonials that share our members struggle with various types of cancer and the positive response they have received
from their use of Poly MVA and other support products
and protocols. To review these
Patient Testimonials, simply click on the
BLUE LINKS
on the right side of the page --->
|
| |
| |
What is Poly-MVA?
"Poly-MVA is the world’s first
metabolic modifier that supports
“chemo & radio therapy” protocols. It supports and enhances
normal metabolic function while selectively targeting the
altered,
anaerobic(low oxygen) metabolism that science has proven is
associated with Cancer & other Degenerative conditions.
Poly-MVA has been scientifically designed to reduce
low oxygen(hypoxic) conditions at the cellular level.
|
|
| |
| |
|
|
| Protective Effects of
Poly-MVA
|
As noted in the myriad of
testimonials found on this site, many of
our members
detail the protective effects Poly-MVA
provided them
as they underwent chemo and radiation treatment. In many
cases, the patients report
increased energy levels,
improved appetite and the
prevention or significant
reduction of hair loss
compared to other patients who did not add Poly-MVA to their
treatment protocol.
Introduction |
| |
|
Poly MVA
is a safe and powerful formulated redox molecule that protects
both cellular DNA & RNA. Poly MVA's scientifically
designed mechanism of action is to
help the cell
“fix itself” while assisting the
body to
control and “fight the cancer”
rather than randomly "poisoning the system"
via chemo and radiation that causes systemic cellular
collateral damage.
Compared to chemotherapy or when taken in combination with
chemotherapy, Poly MVA offers an
extremely powerful Integrative Cancer Treatment
by minimizing the
toxic side effects associated with most Conventional Cancer
Treatments.
| |
| |
| Integrative Oncology vs "Cure
or Kill" Oncology |
|
|
| |
| |
Dr.
Merrill Garnett has done
substantial research and
scientific work in biochemistry and electrochemistry
over a period of 40 years. As the lead
research scientist at the
Garnett McKeen Laboratory, in
Stony Brook, New York, Dr. Garnett is the inventor
and
recipient of
multiple U.S. patents for
the
PolyMVA complex.
|
|
|
|
|
|
| |
| |
| Product Articles |
| |
“Energy to Get the Job Done - Lipoic
Acid
Mineral Complex” |
Dr. Frank Antonawich
|
| |
| |
| |
Providing
Integrative Energy in Cancer:
Metabolically
Targeted Therapy |
 |
|
|
Read Article Here |
| |
| |
| |
Poly-MVA Patented
Dietary Supplement
 |
| |
| |
| |
| |
| |
| |
| |
| Print and Share |
| |
Do you know
someone
with Cancer?
CLICK & PRINT
Print this
graphic and
share our web address. |
|
|
|
|
|
|
|
|
. |
"Cancer Cell Line" testing
performed by this reputable "3rd Party
Cancer Research Lab" clearly demonstrates the
safe, antitumoral activity
of Poly MVA.
| |
In 2007,
KGK
Science, Inc.,
an independent
laboratory in Canada, examined the effects of POLY-MVA on
8
cancer cell lines.
These lines included:
1) Skin melanoma, human (SKMel-5)
2) Liver, hepatocellular carcinoma, human (Hep
G2)
3) Lung, malignant melanoma, human (Malme-3M)
4) Mammary gland, ductal carcinoma, human
(MDA-MB 435)
5) Prostate, left supraclavicular lymph node
carcinoma, human (LNCaP)
6) Colon, colorectal adenocarcinoma, human
(HT-29)
7) Human brain, glioblastoma; astrocytoma
(U87)
8) Glioblastoma (HT-80) |
| |
|
POLY-MVA was
administered at 3 different dosages and the
number of cells was examined after 24, 48
and 72 hours following initial application.
POLY-MVA was effective,
to
varying degrees, on the entire group
of cell lines tested
(melanoma,
liver, lung, breast, prostate, colon,
astrocytoma and
glioblastoma).
|
|
| |
|
Breast Cancer
(Adenocarcinoma)
91.1%
Breast Cancer Cell Death
after 48 Hours
|
Ovarian Cancer
(Adenocarcinoma)
92.07%
Ovarian Cancer Cell Death
after 48 Hours
|
Lung Cancer
(Non-Small
Cell Carcinoma)
83.8%
Lung Cancer Cell Death
after 48 Hours
|
 |
 |
 |
|
| |
|
READ FULL REPORT |
| |
| |
| |
|
